EUVIMEDEUVIMED entdecken
Fallbericht

Clinical and molecular characterization of 2 novel LPL variants in familial chylomicronemia syndrome

Deniz Agirbasli, Baris Karaoglan, Nuri Han Ozalp, Aysel Kalayci

Journal of Clinical Lipidology · 2026-07 · 20 (7) · 1508-1514

DOI: 10.1016/j.jacl.2026.05.009 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Lipidology, 2026-07. Verfasst von Deniz Agirbasli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye (Agirbasli and Kalayci). Hauptthemen laut MEDLINE: Lipoprotein Lipase, Hyperlipoproteinemia Type I. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial chylomicronemia syndrome (FCS) (OMIM #238600) is a rare autosomal recessive disorder characterized by severe hypertriglyceridemia and chylomicronemia due to profound reduction of lipoprotein lipase (LPL). Here, we report 2 unrelated cases of FCS caused by novel homozygous variants in the LPL gene, expanding the known mutational spectrum of this condition. The first case involved a 43-year-old man with longstanding severe hypertriglyceridemia and recurrent acute pancreatitis. Genetic analysis revealed a novel homozygous frameshift variant, c.1172_1173insTCCACAAATAAGA (p.Leu392ProfsTer25), in the LPL gene predicted to result in loss of function. The second case was a female infant presenting with extreme neonatal hypertriglyceridemia, in whom a homozygous missense variant, c.296T>C (p.Leu99Pro), in the LPL gene was identified. Both variants were absent from population databases and identified as novel candidate variants. These cases underscore that phenotypic variability in FCS, ranging from severe neonatal presentation to adult-onset recurrent pancreatitis, is shaped by both the type of the variant and the functional domain involved. Our findings underscore the significance of domain-specific interpretation in genotype-phenotype correlations and identify novel candidate variants for future functional validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein LipaseHyperlipoproteinemia Type IHumansAdultMaleFemaleInfantHomozygoteMutation, Missense

Stichwörter der Autor:innen

Gene variantLPL geneLipoprotein lipasePancreatitisTriglycerides

Substanzen

Lipoprotein LipaseLPL protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye (Agirbasli and Kalayci).
  • Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye (Karaoglan and Ozalp).
  • Department of Medical Genetics, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkiye (Agirbasli and Kalayci). Electronic address: aysel.kalayci@iuc.edu.tr.

Zitieren

APA

Agirbasli, D., Karaoglan, B., Ozalp, N. H., & Kalayci, A. (2026). Clinical and molecular characterization of 2 novel LPL variants in familial chylomicronemia syndrome. Journal of Clinical Lipidology, 20(7), 1508-1514. https://doi.org/10.1016/j.jacl.2026.05.009

Vancouver

Agirbasli D, Karaoglan B, Ozalp NH, Kalayci A. Clinical and molecular characterization of 2 novel LPL variants in familial chylomicronemia syndrome. Journal of Clinical Lipidology. 2026;20(7):1508-1514. doi:10.1016/j.jacl.2026.05.009

BibTeX
@article{Agirbasli2026,
  author = {Agirbasli, Deniz and Karaoglan, Baris and Ozalp, Nuri Han and Kalayci, Aysel},
  title = {Clinical and molecular characterization of 2 novel LPL variants in familial chylomicronemia syndrome},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {7},
  pages = {1508--1514},
  doi = {10.1016/j.jacl.2026.05.009}
}
Kostenlos starten →